Resources & Tools
Tune in to a live webinar on alpha-synuclein – the ‘Parkinson’s protein’
Alpha-synuclein: stopping the sticky protein behind Parkinson's
READ MORE
Prep:
Cook:
Serves:
Scientists in the UK have reported a possible breakthrough in the treatment of Parkinson’s, in the form of a vaccine to block toxins causing the disease.
Researchers say they have found evidence that an abnormal protein may trigger the condition. If that is the case, they suggest that a special vaccine could potentially help a person’s immune system to attack this protein and combat damaging effects – such as the destruction of the cells that create dopamine.
Roger Barker, professor of clinical neurosciences at Cambridge University told the Guardian: “It has transformed the way we see Parkinson’s.”
Alpha-synuclein: stopping the sticky protein behind Parkinson's
READ MORE
The study will take place in London
READ MORE
A partnership helped to expand exercise and therapy sessions in Jerusalem
READ MORE
Comments